{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:24:13Z","timestamp":1791822253956,"version":"4.3.4"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,12]],"date-time":"2012-08-12T00:00:00Z","timestamp":1344729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00702-012-0877-9","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T09:43:01Z","timestamp":1344678181000},"page":"233-252","source":"Crossref","is-referenced-by-count":250,"title":["What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer\u2019s disease, about the therapeutic strategies in Alzheimer\u2019s research"],"prefix":"10.1007","volume":"120","author":[{"given":"Melita","family":"Salkovic-Petrisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Knezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,12]]},"reference":[{"key":"877_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.phrs.2009.12.008","volume":"61","author":"R Agrawal","year":"2010","unstructured":"Agrawal R, Mishra B, Tyagi E, Nath C, Shukla R (2010) Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol Res 61:247\u2013252","journal-title":"Pharmacol Res"},{"key":"877_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.euroneuro.2010.11.009","volume":"21","author":"R Agrawal","year":"2011","unstructured":"Agrawal R, Tyagi E, Shukla R, Nath C (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 21:261\u2013273","journal-title":"Eur Neuropsychopharmacol"},{"key":"877_CR203","doi-asserted-by":"crossref","unstructured":"Akasofu S, Kimura M, Kosasa T, Sawada K, Ogura H (2008) Study of neuroprotection of donepezil, a therapy for Alzheimer's disease. Chem Biol Interact 175:222\u2013226","DOI":"10.1016\/j.cbi.2008.04.045"},{"key":"877_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3233\/JAD-2010-100225","volume":"21","author":"I Arrieta-Cruz","year":"2010","unstructured":"Arrieta-Cruz I, Wang J, Pavlides C, Pasinetti GM (2010) Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 21:649\u2013654","journal-title":"J Alzheimers Dis"},{"key":"877_CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2009.11.007","volume":"86","author":"H Awasthi","year":"2010","unstructured":"Awasthi H, Tota S, Hanif K, Nath C, Shukla R (2010) Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci 86:87\u201394","journal-title":"Life Sci"},{"key":"877_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-2004-6403","volume":"6","author":"L Baum","year":"2004","unstructured":"Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J Alzheimers Dis 6:367\u2013377","journal-title":"J Alzheimers Dis"},{"key":"877_CR204","doi-asserted-by":"crossref","unstructured":"Bi H, Sze CI (2002) N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 200:11\u201318","DOI":"10.1016\/S0022-510X(02)00087-4"},{"key":"877_CR6","first-page":"CD003120","volume":"21","author":"J Birks","year":"2009","unstructured":"Birks J, Grimley Evans J (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 21:CD003120","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0091-3057(93)90497-H","volume":"44","author":"A Blokland","year":"1993","unstructured":"Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44:491\u2013494","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0091-3057(94)90284-4","volume":"47","author":"A Blokland","year":"1994","unstructured":"Blokland A, Jolles J (1994) Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats. Pharmacol Biochem Behav 47:833\u2013837","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR9","first-page":"382","volume":"15","author":"O Blondel","year":"1989","unstructured":"Blondel O, Portha B (1989) Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabete Metab 15:382\u2013387","journal-title":"Diabete Metab"},{"key":"877_CR10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/NEN.0b013e31819ac3cb","volume":"68","author":"M Boimel","year":"2009","unstructured":"Boimel M, Grigoriadis N, Lourbopoulos A, Touloumi O, Rosenmann D, Abramsky O, Rosenmann H (2009) Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuropathol Exp Neurol 68:314\u2013325","journal-title":"J Neuropathol Exp Neurol"},{"key":"877_CR11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","volume":"59","author":"DJ Bonda","year":"2010","unstructured":"Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59:290\u2013294","journal-title":"Neuropharmacology"},{"key":"877_CR12","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.neurobiolaging.2005.09.029","volume":"27","author":"B Borroni","year":"2006","unstructured":"Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Franzoni S, Caltagirone C, Di Luca M, Caimi L, Padovani A (2006) Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 27:1595\u20131603","journal-title":"Neurobiol Aging"},{"key":"877_CR13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","volume":"15","author":"D Bosco","year":"2011","unstructured":"Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011) Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis. J Cell Mol Med 15:1807\u20131821","journal-title":"J Cell Mol Med"},{"key":"877_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(96)00072-6","volume":"302","author":"D Braida","year":"1996","unstructured":"Braida D, Paladini E, Griffini P, Lamperti M, Maggi A, Sala M (1996) An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur J Pharmacol 302:13\u201320","journal-title":"Eur J Pharmacol"},{"key":"877_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN (2011) ADAPT Research Group. Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement 7:402\u2013411","journal-title":"Alzheimers Dement"},{"key":"877_CR16","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","volume":"27","author":"JC Carroll","year":"2007","unstructured":"Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27:13357\u2013133365","journal-title":"J Neurosci"},{"key":"877_CR17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s11064-007-9360-7","volume":"32","author":"RJ Castellani","year":"2007","unstructured":"Castellani RJ, Moreira PI, Liu G, Dobson J, Perry G, Smith MA, Zhu X (2007) Iron: the redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 32:1640\u20131645","journal-title":"Neurochem Res"},{"key":"877_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/biof.1010","volume":"38","author":"RJ Castellani","year":"2012","unstructured":"Castellani RJ, Moreira PI, Perry G, Zhu X (2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. BioFactors 38:133\u2013138","journal-title":"BioFactors"},{"key":"877_CR19","doi-asserted-by":"crossref","unstructured":"Chen S, Liu AR, An FM, Yao WB, Gao XD (2011) Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer\u2019s disease by exendin-4. Age (Dordr) Sep 8 [Epub ahead of print]. doi: 10.1007\/s11357-011-9303-8","DOI":"10.1007\/s11357-011-9303-8"},{"key":"877_CR205","doi-asserted-by":"crossref","unstructured":"Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49:71\u201381","DOI":"10.1016\/S0169-328X(97)00125-3"},{"key":"877_CR20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","volume":"10","author":"SC Correia","year":"2011","unstructured":"Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s disease? Ageing Res Rev 10:264\u2013273","journal-title":"Ageing Res Rev"},{"key":"877_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0253-7613.59925","volume":"41","author":"Y Dalla","year":"2009","unstructured":"Dalla Y, Singh N, Jaggi AS, Singh D, Ghulati P (2009) Potential of ezetimibe in memory deficits associated with dementia of Alzheimer\u2019s type in mice. Indian J Pharmacol 41:262\u2013267","journal-title":"Indian J Pharmacol"},{"key":"877_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1734-1140(10)70339-X","volume":"62","author":"Y Dalla","year":"2010","unstructured":"Dalla Y, Singh N, Jaggi AS, Singh D (2010) Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions. Pharmacol Rep 62:784\u2013796","journal-title":"Pharmacol Rep"},{"key":"877_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/rej.2009.0944","volume":"13","author":"L Danielyan","year":"2010","unstructured":"Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH (2010) Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 13:195\u2013201","journal-title":"Rejuvenation Res"},{"key":"877_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","volume":"7","author":"SM Monte de la","year":"2005","unstructured":"de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer\u2019s disease. J Alzheimers Dis 7:45\u201361","journal-title":"J Alzheimers Dis"},{"key":"877_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","volume":"10","author":"SM Monte de la","year":"2006","unstructured":"de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer\u2019s disease. J Alzheimers Dis 10:89\u2013109","journal-title":"J Alzheimers Dis"},{"key":"877_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000107099","volume":"24","author":"M Degerman Gunnarsson","year":"2007","unstructured":"Degerman Gunnarsson M, Kilander L, Basun H, Lannfelt L (2007) Reduction of phosphorylated tau during memantine treatment of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 24:247\u2013252","journal-title":"Dement Geriatr Cogn Disord"},{"key":"877_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.08.027","volume":"620","author":"R Deshmukh","year":"2009","unstructured":"Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine\u2014a PDE1 inhibitor. Eur J Pharmacol 620:49\u201356","journal-title":"Eur J Pharmacol"},{"key":"877_CR28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jchemneu.2011.10.001","volume":"43","author":"DK Dhull","year":"2012","unstructured":"Dhull DK, Bhateja D, Dhull RK, Padi SS (2012a) Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain. J Chem Neuroanat 43:48\u201351","journal-title":"J Chem Neuroanat"},{"key":"877_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12031-011-9583-6","volume":"46","author":"DK Dhull","year":"2012","unstructured":"Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS (2012b) Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer\u2019s disease in rats. J Mol Neurosci 46:223\u2013235","journal-title":"J Mol Neurosci"},{"key":"877_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3736\/jcim20110215","volume":"9","author":"YC Diwu","year":"2011","unstructured":"Diwu YC, Tian JZ, Shi J (2011) Effects of Chinese herbal medicine Yinsiwei compound on spatial learning and memory ability and the ultrastructure of hippocampal neurons in a rat model of sporadic Alzheimer disease. Zhong Xi Yi Jie He Xue Bao 9:209\u2013215","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"877_CR31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","volume":"5","author":"JC Dodart","year":"2002","unstructured":"Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer\u2019s disease model. Nat Neurosci 5:452\u2013457","journal-title":"Nat Neurosci"},{"key":"877_CR32","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","volume":"25","author":"YF Dong","year":"2011","unstructured":"Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S (2011) Perindopril, a centrally active angiotensin-convertingenzymeinhibitor, prevents cognitive impairment in mouse models of Alzheimer\u2019s disease. FASEB J 25:2911\u20132920","journal-title":"FASEB J"},{"key":"877_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-079X.2011.00864.x","volume":"51","author":"N Dragicevic","year":"2011","unstructured":"Dragicevic N, Copes N, O\u2019Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC (2011) Melatonin treatment restores mitochondrial function in Alzheimer\u2019s mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 51:75\u201386","journal-title":"J Pineal Res"},{"key":"877_CR34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"L Escribano","year":"2010","unstructured":"Escribano L, Sim\u00f3n AM, Gimeno E, Cuadrado-Tejedor M, L\u00f3pez de Maturana R, Garc\u00eda-Osta A, Ricobaraza A, P\u00e9rez-Mediavilla A, Del R\u00edo J, Frechilla D (2010) Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35:1593\u20131604","journal-title":"Neuropsychopharmacology"},{"key":"877_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF (2011) Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 198:351\u2013356","journal-title":"Br J Psychiatry"},{"key":"877_CR36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Fr\u00f6lich","year":"1998","unstructured":"Fr\u00f6lich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Z\u00f6chling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. J Neural Transm 105:423\u2013438","journal-title":"J Neural Transm"},{"key":"877_CR37","doi-asserted-by":"crossref","unstructured":"Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 2012 Mar 19. [Epub ahead of print]. doi: 10.1001\/archneurol.2012.85","DOI":"10.1001\/archneurol.2012.85"},{"key":"877_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","volume":"68","author":"DS Geldmacher","year":"2011","unstructured":"Geldmacher DS, Fritsch T, McClendon MJ, Landreth G (2011) A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease. Arch Neurol 68:45\u201350","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"877_CR39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","volume":"120","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Brindisi M, Tang J (2012) Developing \u03b2-secretase inhibitors for treatment of Alzheimer\u2019s disease. J Neurochem 120(Suppl 1):71\u201383","journal-title":"J Neurochem"},{"key":"877_CR40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/en.130.3.1433","volume":"130","author":"F Giorgino","year":"1992","unstructured":"Giorgino F, Chen JH, Smith RJ (1992) Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight non-receptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose. Endocrinology 130:1433\u20131444","journal-title":"Endocrinology"},{"key":"877_CR41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-7258(94)90055-8","volume":"63","author":"ME G\u00f6tz","year":"1994","unstructured":"G\u00f6tz ME, K\u00fcnig G, Riederer P, Youdim MB (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63:37\u2013122","journal-title":"Pharmacol Ther"},{"key":"877_CR42","first-page":"87","volume":"38","author":"BS Greenwald","year":"1983","unstructured":"Greenwald BS, Davis KL (1983) Experimental pharmacology of Alzheimer disease. Adv Neurol 38:87\u2013102","journal-title":"Adv Neurol"},{"key":"877_CR43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00702-003-0030-x","volume":"111","author":"E Gr\u00fcnblatt","year":"2004","unstructured":"Gr\u00fcnblatt E, Hoyer S, Riederer P (2004) Gene expression profile in streptozotocin rat model for sporadic Alzheimer\u2019s disease. J Neural Transm 111:367\u2013386","journal-title":"J Neural Transm"},{"key":"877_CR44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","volume":"101","author":"E Gr\u00fcnblatt","year":"2007","unstructured":"Gr\u00fcnblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757\u2013770","journal-title":"J Neurochem"},{"key":"877_CR45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-7091-7508-8_30","volume":"54","author":"H Gutzmann","year":"1998","unstructured":"Gutzmann H, Hadler D (1998) Sustained efficacy and safety of idebenone in the treatment of Alzheimer\u2019s disease: update on a 2-year double-blind multicentre study. J Neural Transm Suppl 54:301\u2013310","journal-title":"J Neural Transm Suppl"},{"key":"877_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-211-73574-9_24","volume":"72","author":"K Hager","year":"2007","unstructured":"Hager K, Kenklies M, McAfoose J, Engel J, M\u00fcnch G (2007) Alpha-lipoic acid as a new treatment option for Alzheimer\u2019s disease\u2014a 48\u00a0months follow-up analysis. J Neural Transm Suppl 72:189\u2013193","journal-title":"J Neural Transm Suppl"},{"key":"877_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1533317507309803","volume":"23","author":"IM Hajjar","year":"2008","unstructured":"Hajjar IM, Keown M, Lewis P, Almor A (2008) Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer\u2019s disease: an observational study. Am J Alzheimers Dis Other Demen 23:77\u201383","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"877_CR48","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.08m04606","volume":"70","author":"H Hampel","year":"2009","unstructured":"Hampel H, Ewers M, B\u00fcrger K, Annas P, M\u00f6rtberg A, Bogstedt A, Fr\u00f6lich L, Schr\u00f6der J, Sch\u00f6nknecht P, Riepe MW, Kraft I, Gasser T, Leyhe T, M\u00f6ller HJ, Kurz A, Basun H (2009) Lithium trial in Alzheimer\u2019s disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry 70:922\u2013931","journal-title":"J Clin Psychiatry"},{"key":"877_CR49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","volume":"8","author":"C Harrington","year":"2011","unstructured":"Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M (2011) Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer\u2019s disease: two phase 3 studies. Curr Alzheimer Res 8:592\u2013606","journal-title":"Curr Alzheimer Res"},{"key":"877_CR202","doi-asserted-by":"crossref","unstructured":"Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E (2005) Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry 162:676\u2013682","DOI":"10.1176\/appi.ajp.162.4.676"},{"key":"877_CR50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jnr.490310310","volume":"31","author":"R Hellweg","year":"1992","unstructured":"Hellweg R, Nitsch R, Hock C, Jaksch M, Hoyer S (1992) Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J Neurosci Res 31:479\u2013486","journal-title":"J Neurosci Res"},{"key":"877_CR51","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","volume":"128","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O\u2019Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442\u20131453","journal-title":"Brain"},{"key":"877_CR52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-2011-102079","volume":"25","author":"JH Heo","year":"2011","unstructured":"Heo JH, Lee SR, Lee ST, Lee KM, Oh JH, Jang DP, Chang KT, Cho ZH (2011) Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys. J Alzheimers Dis 25:517\u2013523","journal-title":"J Alzheimers Dis"},{"key":"877_CR206","doi-asserted-by":"crossref","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216\u2013223","DOI":"10.1016\/S0140-6736(08)61075-2"},{"key":"877_CR53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","volume":"290","author":"L Hong","year":"2000","unstructured":"Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J (2000) Structure if the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290:150\u2013153","journal-title":"Science"},{"key":"877_CR54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2011.10.030","volume":"200","author":"Y Hou","year":"2012","unstructured":"Hou Y, Zhou L, Yang QD, Du XP, Li M, Yuan M, Zhou ZW (2012) Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-treated rat model and intervention by using fasudil hydrochloride. Neuroscience 200:120\u2013129","journal-title":"Neuroscience"},{"key":"877_CR55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","volume":"105","author":"S Hoyer","year":"1998","unstructured":"Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415\u2013422","journal-title":"J Neural Transm"},{"key":"877_CR56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490:115\u2013125","journal-title":"Eur J Pharmacol"},{"key":"877_CR57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-211-73574-9_25","volume":"72","author":"S Hoyer","year":"2007","unstructured":"Hoyer S, Lannert H (2007) Long-term abnormalities in brain glucose\/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. J Neural Transm Suppl 72:195\u2013202","journal-title":"J Neural Transm Suppl"},{"key":"877_CR58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11064-006-9168-x","volume":"32","author":"S Hoyer","year":"2007","unstructured":"Hoyer S, Riederer P (2007) Alzheimer disease\u2013no target for statin treatment. A mini review. Neurochem Res 32:695\u2013706","journal-title":"Neurochem Res"},{"key":"877_CR59","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s007020050232","volume":"106","author":"S Hoyer","year":"1999","unstructured":"Hoyer S, Lannert H, N\u00f6ldner M, Chatterjee SS (1999) Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J Neural Transm 106:1171\u20131188","journal-title":"J Neural Transm"},{"key":"877_CR60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2006.03.009","volume":"171","author":"T Ishrat","year":"2006","unstructured":"Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA, Ahmad AS, Islam F (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 171:9\u201316","journal-title":"Behav Brain Res"},{"key":"877_CR61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2009.02.002","volume":"19","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F (2009a) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer\u2019s type (SDAT). Eur Neuropsychopharmacol 19:636\u2013647","journal-title":"Eur Neuropsychopharmacol"},{"key":"877_CR62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FBP.0b013e32832c7125","volume":"20","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Parveen K, Hoda MN, Khan MB, Yousuf S, Ansari MA, Saleem S, Islam F (2009b) Effects of pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats. Behav Pharmacol 20:567\u2013575","journal-title":"Behav Pharmacol"},{"key":"877_CR63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2009.04.010","volume":"1281","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009c) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer\u2019s type. Brain Res 1281:117\u2013127","journal-title":"Brain Res"},{"key":"877_CR64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11357-008-9078-8","volume":"31","author":"AT Isik","year":"2009","unstructured":"Isik AT, Celik T, Ulusoy G, Ongoru O, Elibol B, Doruk H, Bozoglu E, Kayir H, Mas MR, Akman S (2009) Curcumin ameliorates impaired insulin\/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age (Dordr) 31:39\u201349","journal-title":"Age (Dordr)"},{"key":"877_CR65","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","volume":"22","author":"PT Jantzen","year":"2002","unstructured":"Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246\u20132254","journal-title":"J Neurosci"},{"key":"877_CR66","first-page":"CD006378","volume":"2","author":"D Jaturapatporn","year":"2012","unstructured":"Jaturapatporn D, Isaac MG, McCleery J, Tabet N (2012) Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease. Cochrane Database Syst Rev 2:CD006378","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR67","doi-asserted-by":"crossref","unstructured":"Javed H, Khan MM, Ahmad A, Vaibhav K, Ahmad ME, Khan A, Ashafaq M, Islam F, Siddiqui MS, Safhi MM, Islam F (2012) Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience [Epub ahead of print]. doi: 10.1016\/j.neuroscience.2012.02.046","DOI":"10.1016\/j.neuroscience.2012.02.046"},{"key":"877_CR68","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2008.07.078","volume":"443","author":"YS Jee","year":"2008","unstructured":"Jee YS, Ko IG, Sung YH, Lee JW, Kim YS, Kim SE, Kim BK, Seo JH, Shin MS, Lee HH, Cho HJ, Kim CJ (2008) Effects of treadmill exercise on memory and c-Fos expression in the hippocampus of the rats with intracerebroventricular injection of streptozotocin. Neurosci Lett 443:188\u2013192","journal-title":"Neurosci Lett"},{"key":"877_CR69","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF01291887","volume":"104","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"1997","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, de Bustos F, Molina JA, Benito-Le\u00f3n J, Tall\u00f3n-Barranco A, Gasalla T, Ort\u00ed-Pareja M, Guillam\u00f3n F, Rubio JC, Arenas J, Enr\u00edquez-de-Salamanca R (1997) Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer\u2019s disease. J Neural Transm 104:703\u2013710","journal-title":"J Neural Transm"},{"key":"877_CR70","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1016\/S0021-9258(18)89879-9","volume":"259","author":"T Kadowaki","year":"1984","unstructured":"Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takaku F (1984) Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats. J Biol Chem 259:14208\u2013142016","journal-title":"J Biol Chem"},{"key":"877_CR71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1472-8206.2009.00708.x","volume":"23","author":"B Kaur","year":"2009","unstructured":"Kaur B, Singh N, Jaggi AS (2009) Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia. Fundam Clin Pharmacol 23:557\u2013566","journal-title":"Fundam Clin Pharmacol"},{"key":"877_CR72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1196\/annals.1331.025","volume":"1031","author":"K Kontush","year":"2004","unstructured":"Kontush K, Schekatolina S (2004) Vitamin E in neurodegenerative disorders: Alzheimer\u2019s disease. Ann N Y Acad Sci 1031:249\u2013262","journal-title":"Ann N Y Acad Sci"},{"key":"877_CR73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0014-2999(89)90384-1","volume":"166","author":"J Kornhuber","year":"1989","unstructured":"Kornhuber J, Bormann J, Retz W, H\u00fcbers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166:589\u2013590","journal-title":"Eur J Pharmacol"},{"key":"877_CR74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4196\/kjpp.2010.14.5.345","volume":"14","author":"R Kumar","year":"2010","unstructured":"Kumar R, Jaggi AS, Singh N (2010) Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol 14:345\u2013352","journal-title":"Korean J Physiol Pharmacol"},{"key":"877_CR75","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2011.03.040","volume":"189","author":"L Kupershmidt","year":"2011","unstructured":"Kupershmidt L, Weinreb O, Amit T, Mandel S, Bar-Am O, Youdim MB (2011) Novel molecular targets of the neuroprotective\/neurorescue multimodal iron chelating drug M30 in the mouse brain. Neuroscience 189:345\u2013358","journal-title":"Neuroscience"},{"key":"877_CR76","doi-asserted-by":"crossref","unstructured":"Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Weinreb O (2012a) The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major Hallmarks of Alzheimer\u2019s disease. antioxid redox signal. [Epub ahead of print]. doi: 10.1089\/ars.2011.4279","DOI":"10.1089\/ars.2011.4279"},{"key":"877_CR77","doi-asserted-by":"crossref","unstructured":"Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Weinreb O (2012b) Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice. Mech Ageing Dev. [Epub ahead of print]. doi: 10.1016\/j.mad.2012.03.001","DOI":"10.1016\/j.mad.2012.03.001"},{"key":"877_CR78","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0735-7044.112.5.1199","volume":"112","author":"H Lannert","year":"1998","unstructured":"Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199\u20131208","journal-title":"Behav Neurosci"},{"key":"877_CR79","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s007020050111","volume":"105","author":"H Lannert","year":"1998","unstructured":"Lannert H, Wirtz P, Schuhmann V, Galmbacher R (1998) Effects of Estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin. J Neural Transm 105:1045\u20131063","journal-title":"J Neural Transm"},{"key":"877_CR80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease. J Alzheimers Dis 9:13\u201333","journal-title":"J Alzheimers Dis"},{"key":"877_CR81","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/JAD-2002-4601","volume":"4","author":"JA Levin-Allerhand","year":"2002","unstructured":"Levin-Allerhand JA, Lominska CE, Wang J, Smith JD (2002) 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J Alzheimers Dis 4:449\u2013457","journal-title":"J Alzheimers Dis"},{"key":"877_CR82","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2011.11.005","volume":"674","author":"L Li","year":"2012","unstructured":"Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ (2012) (Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. Eur J Pharmacol 674:280\u2013286","journal-title":"Eur J Pharmacol"},{"key":"877_CR83","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s007020100020","volume":"108","author":"T L\u00f6ffler","year":"2001","unstructured":"L\u00f6ffler T, Lee SK, N\u00f6ldner M, Chatterjee SS, Hoyer S, Schliebs R (2001) Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain. J Neural Transm 108:1457\u20131474","journal-title":"J Neural Transm"},{"key":"877_CR84","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078\u20139089","journal-title":"J Neurosci"},{"key":"877_CR85","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(90)91747-5","volume":"532","author":"G Mayer","year":"1990","unstructured":"Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 532:95\u2013100","journal-title":"Brain Res"},{"key":"877_CR86","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2007","unstructured":"McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28:639\u2013647","journal-title":"Neurobiol Aging"},{"key":"877_CR87","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2174\/138161210793176581","volume":"16","author":"M Medina","year":"2010","unstructured":"Medina M, Avila J (2010) Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer\u2019s disease. Curr Pharm Des 16:2790\u20132798","journal-title":"Curr Pharm Des"},{"key":"877_CR88","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.05.001","volume":"141","author":"T Melnikova","year":"2006","unstructured":"Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model. Neuroscience 141:1149\u20131162","journal-title":"Neuroscience"},{"key":"877_CR89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","volume":"311","author":"R Minkeviciene","year":"2004","unstructured":"Minkeviciene R, Banerjee P, Tanila H (2004) Memantine improves spatial learning in a transgenic mouse model of Alzheimer\u2019s disease. J Pharmacol Exp Ther 311:677\u2013682","journal-title":"J Pharmacol Exp Ther"},{"key":"877_CR90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2011.03.026","volume":"659","author":"S Misra","year":"2011","unstructured":"Misra S, Tiwari V, Kuhad A, Chopra K (2011) Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats. Eur J Pharmacol 659:177\u2013186","journal-title":"Eur J Pharmacol"},{"key":"877_CR91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","volume":"18","author":"SA Montgomery","year":"2003","unstructured":"Montgomery SA, Thal LJ, Amrein R (2003) Meta-analysis of double blind randomized controlled clinical trials of acetyl-l-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer\u2019s disease. Int Clin Psychopharmacol 18:61\u201371","journal-title":"Int Clin Psychopharmacol"},{"key":"877_CR92","doi-asserted-by":"crossref","unstructured":"Muller AP, Zimmer ER, Kalinine E, Haas CB, Oses JP, Martimbianco de Assis A, Galina A, Souza DO, Portela LV (2012) Physical exercise exacerbates memory deficits induced by intracerebroventricular STZ but improves insulin regulation of H2O2 production in mice synaptosomes. J Alzheimers Dis. [Epub ahead of print]. doi: 10.3233\/JAD-2012-112066","DOI":"10.3233\/JAD-2012-112066"},{"key":"877_CR93","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","volume":"283","author":"RA Mulnard","year":"2000","unstructured":"Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer\u2019s Disease Cooperative Study. JAMA 283:1007\u20131015","journal-title":"JAMA"},{"key":"877_CR94","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"Li Nc","year":"2010","unstructured":"Nc Li, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:b5465. doi: 10.1136\/bmj.b5465","journal-title":"BMJ"},{"key":"877_CR95","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","volume":"28","author":"N Nicolakakis","year":"2008","unstructured":"Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, Hamel E (2008) Complete rescue of cerebrovascular function in aged Alzheimer\u2019s disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 28:9287\u20139296","journal-title":"J Neurosci"},{"key":"877_CR96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(91)90260-Z","volume":"128","author":"R Nitsch","year":"1991","unstructured":"Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199\u2013202","journal-title":"Neurosci Lett"},{"key":"877_CR97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","volume":"483","author":"J Nunan","year":"2000","unstructured":"Nunan J, Small DH (2000) Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 483:6\u201310","journal-title":"FEBS Lett"},{"key":"877_CR98","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281:39413\u201339423","journal-title":"J Biol Chem"},{"key":"877_CR99","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","volume":"79","author":"AR Pathan","year":"2006","unstructured":"Pathan AR, Viswanad B, Sonkusare SK, Ramarao P (2006) Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 79:2209\u20132216","journal-title":"Life Sci"},{"key":"877_CR100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","volume":"199","author":"WA Pedersen","year":"2006","unstructured":"Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199:265\u2013273","journal-title":"Exp Neurol"},{"key":"877_CR101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.wad.0000155067.16313.5e","volume":"19","author":"ER Peskind","year":"2005","unstructured":"Peskind ER, Tsuang DW, Bonner LT, Pascualy M, Riekse RG, Snowden MB, Thomas R, Raskind MA (2005) Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer Dis Assoc Disord 19:23\u201328","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"877_CR102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2010.01.057","volume":"472","author":"S Pinton","year":"2010","unstructured":"Pinton S, da Rocha JT, Zeni G, Nogueira CW (2010) Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity. Neurosci Lett 472:56\u201360","journal-title":"Neurosci Lett"},{"key":"877_CR103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cbf.1741","volume":"29","author":"S Pinton","year":"2011","unstructured":"Pinton S, da Rocha JT, Gai BM, Prigol M, da Rosa LV, Nogueira CW (2011) Neuroprotector effect of p,p\u2032-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer\u2019s type in mice: contribution of antioxidant mechanism. Cell Biochem Funct 29:235\u2013243","journal-title":"Cell Biochem Funct"},{"key":"877_CR201","doi-asserted-by":"crossref","unstructured":"Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11:477\u2013483","DOI":"10.1016\/0736-5748(93)90021-5"},{"key":"877_CR104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2011.09.056","volume":"1426","author":"T Ponce-Lopez","year":"2011","unstructured":"Ponce-Lopez T, Liy-Salmeron G, Hong E, Meneses A (2011) Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3\u03b2 decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. Brain Res 1426:73\u201385","journal-title":"Brain Res"},{"key":"877_CR105","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1211\/jpp\/61.12.0012","volume":"61","author":"AK Prakash","year":"2009","unstructured":"Prakash AK, Kumar A (2009) Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats. J Pharm Pharmacol 61:1665\u20131672","journal-title":"J Pharm Pharmacol"},{"key":"877_CR106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-8993(95)00006-C","volume":"674","author":"J Prickaerts","year":"1995","unstructured":"Prickaerts J, Blokland A, Honig W, Meng F, Jolles J (1995) Spatial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats: effects of chronic treatment with acetyl-l-carnitine. Brain Res 674:142\u2013146","journal-title":"Brain Res"},{"key":"877_CR107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-4328(98)00158-2","volume":"102","author":"J Prickaerts","year":"1999","unstructured":"Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102:73\u201388","journal-title":"Behav Brain Res"},{"key":"877_CR108","first-page":"369808","volume":"2012","author":"C Reitz","year":"2012","unstructured":"Reitz C (2012) Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012:369808","journal-title":"Int J Alzheimers Dis"},{"key":"877_CR109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbr.2008.02.005","volume":"190","author":"H Richter","year":"2008","unstructured":"Richter H, Ambr\u00e9e O, Lewejohann L, Herring A, Keyvani K, Paulus W, Palme R, Touma C, Sch\u00e4bitz WR, Sachser N (2008) Wheel-running in a transgenic mouse model of Alzheimer\u2019s disease: protection or symptom? Behav Brain Res 190:74\u201384","journal-title":"Behav Brain Res"},{"key":"877_CR110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00210-010-0511-z","volume":"381","author":"P Rinwa","year":"2010","unstructured":"Rinwa P, Kaur B, Jaggi AS, Singh N (2010) Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. Naunyn Schmiedebergs Arch Pharmacol 381:529\u2013539","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"877_CR111","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bmcl.2007.11.028","volume":"18","author":"C Riviere","year":"2008","unstructured":"Riviere C, Richard T, Vitrac X, Merillon JM, Valls J, Monti JP (2008) New polyphenols active on beta-amyloid aggregation. Bioorg Med Chem Lett 18:828\u2013831","journal-title":"Bioorg Med Chem Lett"},{"key":"877_CR112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2009-1034","volume":"17","author":"L Rodrigues","year":"2009","unstructured":"Rodrigues L, Biasibetti R, Swarowsky A, Leite MC, Quincozes-Santos A, Quilfeldt JA, Achaval M, Gon\u00e7alves CA (2009) Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine. J Alzheimers Dis 17:193\u2013202","journal-title":"J Alzheimers Dis"},{"key":"877_CR113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-010-0501-9","volume":"117","author":"L Rodrigues","year":"2010","unstructured":"Rodrigues L, Dutra MF, Ilha J, Biasibetti R, Quincozes-Santos A, Leite MC, Marcuzzo S, Achaval M, Gon\u00e7alves CA (2010) Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J Neural Transm 117:1295\u20131305","journal-title":"J Neural Transm"},{"key":"877_CR114","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","volume":"72","author":"M Salkovic-Petrisic","year":"2007","unstructured":"Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 72:217\u2013233","journal-title":"J Neural Transm Suppl"},{"key":"877_CR115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2005.03637.x","volume":"96","author":"M Salkovic-Petrisic","year":"2006","unstructured":"Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005\u20131015","journal-title":"J Neurochem"},{"key":"877_CR116","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-2009-1184","volume":"18","author":"M Salkovic-Petrisic","year":"2009","unstructured":"Salkovic-Petrisic M, Osmanovic J, Gr\u00fcnblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer\u2019s disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis 18:729\u2013750","journal-title":"J Alzheimers Dis"},{"key":"877_CR117","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","volume":"118","author":"M Salkovic-Petrisic","year":"2011","unstructured":"Salkovic-Petrisic M, Osmanovic-Barilar J, Br\u00fcckner MK, Hoyer S, Arendt T, Riederer P (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer\u2019s disease: a long-term follow up study. J Neural Transm 118:765\u2013772","journal-title":"J Neural Transm"},{"key":"877_CR118","unstructured":"Salkovic-Petrisic M, Hoyer S, Riederer P (2012) Experimental approach to Alzheimer disease (in print)"},{"key":"877_CR119","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","volume":"32","author":"T Sato","year":"2011","unstructured":"Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T (2011) Efficacy of PPAR-\u03b3 agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 32:1626\u20131633","journal-title":"Neurobiol Aging"},{"key":"877_CR120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.pbb.2007.03.010","volume":"86","author":"G Saxena","year":"2007","unstructured":"Saxena G, Singh SP, Pal R, Singh S, Pratap R, Nath C (2007) Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochem Behav 86:797\u2013805","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejphar.2007.12.009","volume":"581","author":"G Saxena","year":"2008","unstructured":"Saxena G, Singh SP, Agrawal R, Nath C (2008) Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol 581:283\u2013289","journal-title":"Eur J Pharmacol"},{"key":"877_CR122","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pbb.2009.09.022","volume":"94","author":"G Saxena","year":"2010","unstructured":"Saxena G, Bharti S, Kamat PK, Sharma S, Nath C (2010) Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol Biochem Behav 94:397\u2013403","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR123","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbr.2011.04.039","volume":"224","author":"G Saxena","year":"2011","unstructured":"Saxena G, Patro IK, Nath C (2011) ICV STZ induced impairment in memory and neuronal mitochondrial function: a protective role of nicotinic receptor. Behav Brain Res 224:50\u201357","journal-title":"Behav Brain Res"},{"key":"877_CR124","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0024-3205(00)01005-5","volume":"68","author":"M Sharma","year":"2001","unstructured":"Sharma M, Gupta YK (2001) Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 68:1021\u20131029","journal-title":"Life Sci"},{"key":"877_CR125","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0024-3205(02)02083-0","volume":"71","author":"M Sharma","year":"2002","unstructured":"Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489\u20132498","journal-title":"Life Sci"},{"key":"877_CR126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0924-977X(03)00008-7","volume":"13","author":"M Sharma","year":"2003","unstructured":"Sharma M, Gupta YK (2003) Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharmacol 13:241\u2013247","journal-title":"Eur Neuropsychopharmacol"},{"key":"877_CR127","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0269881107081553","volume":"22","author":"B Sharma","year":"2008","unstructured":"Sharma B, Singh N, Singh M (2008a) Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer\u2019s disease by pitavastatin and donepezil. J Psychopharmacol 22:162\u2013171","journal-title":"J Psychopharmacol"},{"key":"877_CR128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.pbb.2008.02.012","volume":"89","author":"B Sharma","year":"2008","unstructured":"Sharma B, Singh N, Singh M, Jaggi AS (2008b) Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav 89:535\u2013545","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pbb.2012.01.004","volume":"101","author":"V Sharma","year":"2012","unstructured":"Sharma V, Bala A, Deshmukh R, Bedi KL, Sharma PL (2012) Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 101:239\u2013245","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","volume":"68","author":"NE Shepardson","year":"2011","unstructured":"Shepardson NE, Shankar GM, Selkoe DJ (2011a) Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 68:1239\u20131244","journal-title":"Arch Neurol"},{"key":"877_CR131","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","volume":"68","author":"NE Shepardson","year":"2011","unstructured":"Shepardson NE, Shankar GM, Selkoe DJ (2011b) Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68:1385\u20131392","journal-title":"Arch Neurol"},{"key":"877_CR132","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbr.2012.01.034","volume":"229","author":"AS Shingo","year":"2012","unstructured":"Shingo AS, Kanabayashi T, Murase T, Kito S (2012) Cognitive decline in STZ-3\u00a0V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res 229:378\u2013383","journal-title":"Behav Brain Res"},{"key":"877_CR133","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuropharm.2006.10.005","volume":"52","author":"S Shoham","year":"2007","unstructured":"Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M (2007) Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52:836\u2013843","journal-title":"Neuropharmacology"},{"key":"877_CR134","doi-asserted-by":"crossref","unstructured":"Shonesy BC, Thiruchelvam K, Parameshwaran K, Rahman EA, Karuppagounder SS, Huggins KW, Pinkert CA, Amin R, Dhanasekaran M, Suppiramaniam V (2012) Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiol Aging 33:430.e5\u2013430.e18","DOI":"10.1016\/j.neurobiolaging.2010.12.002"},{"key":"877_CR135","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","volume":"289","author":"SA Shumaker","year":"2003","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651\u20132662","journal-title":"JAMA"},{"key":"877_CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2004.10.036","volume":"77","author":"S Sonkusare","year":"2005","unstructured":"Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1\u201314","journal-title":"Life Sci"},{"key":"877_CR137","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0014-4886(03)00399-6","volume":"184","author":"RW Stackman","year":"2003","unstructured":"Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF (2003) Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer\u2019s disease by chronic Ginkgo biloba treatment. Exp Neurol 184:510\u2013520","journal-title":"Exp Neurol"},{"key":"877_CR138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? J Alzheimer\u2019s Dis 7:63\u201380","journal-title":"J Alzheimer\u2019s Dis"},{"key":"877_CR139","first-page":"537","volume":"50","author":"T Szkudelski","year":"2001","unstructured":"Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cell of the rat pancreas. Physiol Res 50:537\u2013546","journal-title":"Physiol Res"},{"key":"877_CR140","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1039\/c0mb00302f","volume":"7","author":"S Takeda","year":"2011","unstructured":"Takeda S, Sato N, Rakugi H, Morishita R (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol BioSyst 7:1822\u20131827","journal-title":"Mol BioSyst"},{"key":"877_CR141","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18632\/aging.100267","volume":"3","author":"J Tang","year":"2011","unstructured":"Tang J, Ghosh A (2011) Treating transgenic Alzheimer mice with a \u03b2-secretase inhibitor, what have we learned? Aging (Albany NY) 3:14\u201316","journal-title":"Aging (Albany NY)"},{"key":"877_CR142","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(95)00475-4","volume":"287","author":"D Terwel","year":"1995","unstructured":"Terwel D, Prickaerts J, Meng F, Jolles J (1995) Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-l-carnitine. Eur J Pharmacol 287:65\u201371","journal-title":"Eur J Pharmacol"},{"key":"877_CR143","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","volume":"61","author":"LJ Thal","year":"2003","unstructured":"Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MF, Zamrini E, Thomas RG (2003) Idebenone treatment fails to slow cognitive decline in Alzheimer\u2019s disease. Neurology 61:1498\u20131502","journal-title":"Neurology"},{"key":"877_CR144","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pbb.2009.05.009","volume":"93","author":"V Tiwari","year":"2009","unstructured":"Tiwari V, Kuhad A, Bishnoi M, Chopra K (2009) Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav 93:183\u2013189","journal-title":"Pharmacol Biochem Behav"},{"key":"877_CR145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/mp.2009.72","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer\u2019s disease. Mol Psychiatry 15:272\u2013285","journal-title":"Mol Psychiatry"},{"key":"877_CR146","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2008.11.044","volume":"199","author":"S Tota","year":"2009","unstructured":"Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, Hanif K (2009) Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 199:235\u2013240","journal-title":"Behav Brain Res"},{"key":"877_CR147","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2010.01.017","volume":"209","author":"S Tota","year":"2010","unstructured":"Tota S, Awasthi H, Kamat PK, Nath C, Hanif K (2010) Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 209:73\u201379","journal-title":"Behav Brain Res"},{"key":"877_CR148","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2011.02.041","volume":"221","author":"S Tota","year":"2011","unstructured":"Tota S, Kamat PK, Shukla R, Nath C (2011) Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 221:207\u2013215","journal-title":"Behav Brain Res"},{"key":"877_CR149","first-page":"317","volume":"226","author":"S Tota","year":"2012","unstructured":"Tota S, Kamat PK, Saxena G, Hanif K, Najmi AK, Nath C (2012) Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats. BehavBrain Res 226:317\u2013330","journal-title":"BehavBrain Res"},{"key":"877_CR150","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00702-011-0680-z","volume":"118","author":"AC Tramontina","year":"2011","unstructured":"Tramontina AC, Wartchow KM, Rodrigues L, Biasibetti R, Quincozes-Santos A, Bobermin L, Tramontina F, Gon\u00e7alves CA (2011) The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer\u2019s disease in rats. J Neural Transm 118:1641\u20131649","journal-title":"J Neural Transm"},{"key":"877_CR151","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","volume":"22","author":"S Tzimopoulou","year":"2010","unstructured":"Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM (2010) A multi-center randomized proof-of-concept clinical trial applying [18F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer\u2019s disease. J Alzheimers Dis 22:1241\u20131256","journal-title":"J Alzheimers Dis"},{"key":"877_CR152","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euroneuro.2005.06.005","volume":"16","author":"D Dam Van","year":"2006","unstructured":"Van Dam D, De Deyn PP (2006) Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. Eur Neuropsychopharmacol 16:59\u201369","journal-title":"Eur Neuropsychopharmacol"},{"key":"877_CR153","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1440-1681.2003.03842.x","volume":"30","author":"MH Veerendra Kumar","year":"2003","unstructured":"Veerendra Kumar MH, Gupta YK (2003) Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer\u2019s disease in rats. Clin Exp Pharmacol Physiol 30:336\u2013342","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"877_CR154","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2202-9-S2-S6","volume":"9","author":"V Vingtdeux","year":"2008","unstructured":"Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in Alzheimer\u2019s disease. BMC Neurosci 9:S6","journal-title":"BMC Neurosci"},{"key":"877_CR155","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1096\/fj.06-6281com","volume":"20","author":"J Wang","year":"2006","unstructured":"Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM (2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer\u2019s disease. FASEB J 20:2313\u20132320","journal-title":"FASEB J"},{"key":"877_CR156","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12640-009-9000-x","volume":"15","author":"YJ Wang","year":"2009","unstructured":"Wang YJ, Thomas P, Zhong JH, Bi FF, Kosaraju S, Pollard A, Fenech M, Zhou XF (2009) Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer\u2019s disease mouse. Neurotox Res 15:3\u201314","journal-title":"Neurotox Res"},{"key":"877_CR157","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2001.tb03622.x","volume":"939","author":"M Weinstock","year":"2001","unstructured":"Weinstock M, Kirschbaum-Slager N, Lazarovici P, Bejar C, Youdim MB, Shoham S (2001) Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. Ann N Y Acad Sci 939:148\u2013161","journal-title":"Ann N Y Acad Sci"},{"key":"877_CR158","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000119366","volume":"36","author":"G Weyer","year":"1997","unstructured":"Weyer G, Babej-D\u00f6lle RM, Hadler D, Hofmann S, Herrmann WM (1997) A controlled study of 2 doses of idebenone in the treatment of Alzheimer\u2019s disease. Neuropsychobiology 36:73\u201382","journal-title":"Neuropsychobiology"},{"key":"877_CR159","first-page":"223","volume":"15","author":"KA Wollen","year":"2010","unstructured":"Wollen KA (2010) Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev 15:223\u2013244","journal-title":"Altern Med Rev"},{"key":"877_CR160","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","volume":"23","author":"Q Yan","year":"2003","unstructured":"Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease. J Neurosci 23:7504\u20137509","journal-title":"J Neurosci"},{"key":"877_CR161","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/S1353-8020(11)70422-9","volume":"18","author":"MB Youdim","year":"2012","unstructured":"Youdim MB (2012) M30, a brain permeable multi target neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models. Parkinsonism Relat Disord 18:S151\u2013S154","journal-title":"Parkinsonism Relat Disord"},{"key":"877_CR162","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mad.2004.08.023","volume":"126","author":"MB Youdim","year":"2005","unstructured":"Youdim MB, Fridkin M, Zheng H (2005) Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech Ageing Dev 126:317\u2013326","journal-title":"Mech Ageing Dev"},{"key":"877_CR163","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","volume":"33","author":"KR Zahs","year":"2010","unstructured":"Zahs KR, Ashe KH (2010) Too much good news\u2019\u2014are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease? Trends Neurosci 33:381\u2013389","journal-title":"Trends Neurosci"},{"key":"877_CR164","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-2011-101875","volume":"24","author":"X Zhang","year":"2011","unstructured":"Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, Du Y, Doody RS, Le W (2011) Long-term treatment with lithium alleviates memory deficits and reduces amyloid-\u03b2 production in an aged Alzheimer\u2019s disease transgenic mouse model. J Alzheimers Dis 24:739\u2013749","journal-title":"J Alzheimers Dis"},{"key":"877_CR165","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1007\/s00018-007-7218-4","volume":"64","author":"X Zhu","year":"2007","unstructured":"Zhu X, Su B, Wang X, Smith MA, Perry G (2007) Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64:2202\u20132210","journal-title":"Cell Mol Life Sci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0877-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T09:44:02Z","timestamp":1643190242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,12]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0877-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,12]]}}}